Profile
| Metric | Value |
|---|---|
| Full Name | Immunovant, Inc. |
| Ticker | NASDAQ: IMVT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | immunovant.com |
| Employees | 362 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $24.78 | |
| Price, 1D Change | -1.47% | |
| $5B | ||
| - | ||
| - | ||
| 1.01 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.73 | ||
| EPS, 1Y Change | -45.39% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | HSAC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.73 | ||
| EPS Estimate | N/A | -$2.93 |
| EPS Est. Change | N/A | -7.18% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $24.78 | |
| Price Target | - | $43.00 |
| Price Tgt. Change | - | +73.53% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.77 | -$1.88 | -6.10% | |
| -$2.87 | -$2.73 | +5.00% | |
| -$2.93 | N/A | -7.18% | |
| -$3.00 | N/A | -9.83% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $17.16M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $24.78 | |
| $19.03 | ||
| SMA 200 vs Price | -23.19% | |
| $25.37 | ||
| SMA 50 vs Price | +2.39% | |
| 1.01 | ||
| $1.15 | ||
| 43.94 | ||
| 27.29% | ||
| 57.18% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.73 | ||
| -$377.00K | ||
| - | ||
| -$438.15M | ||
| - | ||
| -$413.84M | ||
| - | ||
| -$437.78M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 11.16 | ||
| 11.16 | ||
| - | ||
| - | ||
| 39.86 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 9.61 | ||
| -9.19 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $707.45M | ||
| $713.97M | ||
| $777.32M | ||
| $767.66M | ||
| $69.87M | ||
| $68.78M | ||
| $98.00K | ||
| $98.00K | ||
| $17.66M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $413.84M | ||
| $437.78M | ||
| $377.00K | ||
| $0.00 | ||
| $377.00K | ||
| $0.00 | ||
| $891.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$375.87M | ||
| -$759.00K | ||
| $454.49M | ||
| $759.00K | ||
| -$376.63M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Truist Securities | → | |
| Wolfe Research | → | |
| Goldman Sachs | → | |
| Truist Securities | ||
| JP Morgan | → | |
| HC Wainwright & Co. | → | |
| JP Morgan | → | |
| B of A Securities | → | |
| UBS | → | |
| UBS | → |
Analyst sentiment
Institutional ownership
Screeners with IMVT
FAQ
What is the ticker symbol for Immunovant, Inc.?
The ticker symbol for Immunovant, Inc. is NASDAQ:IMVT
Does Immunovant, Inc. pay dividends?
No, Immunovant, Inc. does not pay dividends
What sector is Immunovant, Inc. in?
Immunovant, Inc. is in the Healthcare sector
What industry is Immunovant, Inc. in?
Immunovant, Inc. is in the Biotechnology industry
What country is Immunovant, Inc. based in?
Immunovant, Inc. is headquartered in United States
When did Immunovant, Inc. go public?
Immunovant, Inc. initial public offering (IPO) was on June 21, 2019
Is Immunovant, Inc. in the S&P 500?
No, Immunovant, Inc. is not included in the S&P 500 index
Is Immunovant, Inc. in the NASDAQ 100?
No, Immunovant, Inc. is not included in the NASDAQ 100 index
Is Immunovant, Inc. in the Dow Jones?
No, Immunovant, Inc. is not included in the Dow Jones index
When was Immunovant, Inc. last earnings report?
Immunovant, Inc.'s most recent earnings report was on November 10, 2025
When does Immunovant, Inc. report earnings?
The next expected earnings date for Immunovant, Inc. is February 6, 2026
Data Sources & References
- IMVT Official Website immunovant.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1764013/000176401325000149/0001764013-25-000149-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1764013/000176401325000092/0001764013-25-000092-index.htm
- IMVT Profile on Yahoo Finance finance.yahoo.com/quote/IMVT
- IMVT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/imvt